, , -1,
Last Published 05.01.2026 Effective Date: 04.01.2026 This policy addresses electromagnetic therapy for wounds
If you need to pause for more than two weeks, contact your healthcare provider about restartingsome may recommend resuming at a lower dose
C., D'Alessio, D

Disclosures: Amon Asgharpour: Galectin: Clinical Endpoint Committee, NovoNordisk: Advisor, Madrigal: Advisor, Laura Wilson: Nothing to Disclose, Raj Vuppalanchi: Nothing to Disclose, Katherine Yates: Nothing to Disclose, Srinivasan Dasarathy: Nothing to Disclose, Kris Kowdley: Nothing to Disclose, Anna Mae Diehl: Nothing to Disclose, Rohit Loomba: Eli Lilly and Company: Consultant, Brent Neuschwander-Tetri: Akero: Consultant, Aligos: Consultant, Arrowhead: Consultant, Corcept: Consultant, GSK: Consultant, Hepion: Consultant, HIstoIndex: Consultant, Madrigal: Consultant, Madrigal: Grant/Research Support, Merck: Consultant, Mirum: Consultant, Sagimet: Consultant, Senseion: Consultant, HepGene: Stock privately held company, HeptaBio: Stock privately held company, Norah Terrault: Elseiver: Royalties or patent beneficiary, GSK: Grant/Research Support, Eiger Pharmaceuticals: Grant/Research Support, Helio Health: Grant/Research Support, Durect Corp: Grant/Research Support, ImmunoCore: Grant/Research Support, HBV Foundation: Board member, AASLD: Executive role, Bilal Hameed: Gilead: Grant/Research Support, Intercept: Grant/Research Support, Pliant: Grant/Research Support, Novo Nordisk: Grant/Research Support, Madrigal: Grant/Research Support, Salix: Grant/Research Support, Mallinckrodt: Advisor, Pleiogenix: Advisor, CLDF: Advisor, Gilead: Consultant, Pioneering Medicine VII Inc: Consultant, Surrozen: Consultant, Pleiogenix: Stock privately held company, Scholars In Medicine: Speaking and Teaching, Emily Mitchell: Nothing to Disclose, Oscar Cummings: Nothing to Disclose, Cynthia Behling: Pacific Rim Pathology Lab: Employee, Novo Nordisk: Consultant, Pathology Institute: Consultant, James Tonascia: Nothing to Disclose, Arun Sanyal: Genfit, Akarna, Tiziana, Durect, Inversago, Hemoshear, North: Stock - publicly traded company, Astra Zeneca ( 60K), Boston Pharmaceutical ( 2

For more frequent symptoms, histamine-2 receptor antagonists (H2RAs) such as famotidine may be used, though patients should be counseled that these medications may take 30-60 minutes to provide relief